While EA‐ST36 had no significant effect on soluble phosphorylated tau levels in HFD‐fed 3xTg‐AD mice (Figure 4A,B), it markedly reduced sarkosyl‐insoluble phosphorylated tau (AT8) aggregates, indicating enhanced clearance of pathological tau species (Figure 4B). Here, MAPT is linked to Alzheimer disease.